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ABSTRACT Heteroresistance refers to phenotypic heterogeneity of microbial clonal populations under antibiotic stress, and it has
been thought to be an allocation of a subset of “resistant” cells for surviving in higher concentrations of antibiotic. The assump-
tion fits the so-called bet-hedging strategy, where a bacterial population “hedges” its “bet” on different phenotypes to be selected
by unpredicted environment stresses. To test this hypothesis, we constructed a heteroresistance model by introducing a
blaCTX-M-14 gene (coding for a cephalosporin hydrolase) into a sensitive Escherichia coli strain. We confirmed heteroresistance in
this clone and that a subset of the cells expressed more hydrolase and formed more colonies in the presence of ceftriaxone (ex-
hibited stronger “resistance”). However, subsequent single-cell-level investigation by using a microfluidic device showed that a
subset of cells with a distinguishable phenotype of slowed growth and intensified hydrolase expression emerged, and they were
not positively selected but increased their proportion in the population with ascending antibiotic concentrations. Therefore,
heteroresistance—the gradually decreased colony-forming capability in the presence of antibiotic—was a result of a decreased
growth rate rather than of selection for resistant cells. Using a mock strain without the resistance gene, we further demonstrated
the existence of two nested growth-centric feedback loops that control the expression of the hydrolase and maximize population
growth in various antibiotic concentrations. In conclusion, phenotypic heterogeneity is a population-based strategy beneficial
for bacterial survival and propagation through task allocation and interphenotypic collaboration, and the growth rate provides a
critical control for the expression of stress-related genes and an essential mechanism in responding to environmental stresses.
IMPORTANCE Heteroresistance is essentially phenotypic heterogeneity, where a population-based strategy is thought to be at
work, being assumed to be variable cell-to-cell resistance to be selected under antibiotic stress. Exact mechanisms of heteroresis-
tance and its roles in adaptation to antibiotic stress have yet to be fully understood at the molecular and single-cell levels. In our
study, we have not been able to detect any apparent subset of “resistant” cells selected by antibiotics; on the contrary, cell popu-
lations differentiate into phenotypic subsets with variable growth statuses and hydrolase expression. The growth rate appears to
be sensitive to stress intensity and plays a key role in controlling hydrolase expression at both the bulk population and single-cell
levels. We have shown here, for the first time, that phenotypic heterogeneity can be beneficial to a growing bacterial population
through task allocation and interphenotypic collaboration other than partitioning cells into different categories of selective ad-
vantage.
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The increasing antibiotic resistance of bacterial pathogens is ofgreat concern worldwide. The exploration of possible mecha-
nisms of such resistance has led to intensive investigations of het-
eroresistance: phenotypic heterogeneous resistance to an antibi-
otic treatment within a clonal population (1–3). In laboratory
practice, such resistant subpopulations emerge as resistant colo-
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nies grown inside the inhibitory halos in Etest and lead to a grad-
ual decrease in the colony count on agar plates as the antibiotic
concentration increases in a population analysis profile (PAP) as-
say (4).
Heteroresistance is observed in a wide range of microbes (5–7)
and often in cases of treatment failures (8, 9); it has been thought
to be a prerequisite of resistant subpopulations that lead to full
resistance due to their selective advantages upon antibiotic stress
(10–12). However, this speculation remains controversial because
the “resistant” colonies do not always give rise to resistant proge-
nies or converge to a homotypic fully resistant phenotype after
antibiotic selection (7). In addition, the genetic basis of heterore-
sistance remains obscure, although attempts to discover it have
been made (13, 14) and a single resistant gene, mecA, has been
reported to be responsible for heteroresistance in Staphylococcus
aureus (15).
Although heteroresistance generally refers to a subset of phe-
notypically resistant cells from antibiotic-sensitive clinical iso-
lates, phenotypic heterogeneity in terms of antibiotic resistance
has often been observed in resistant strains. In fact, a sensitive or
resistant strain is recognized according to artificial criteria, and
the heteroresistance of these strains may share common mecha-
nisms that vary only with the resistance mode. Here, our study was
focused on a particular case where a hydrolase was used to con-
struct a simple cellular model: a plasmid containing a gene encod-
ing an extended-spectrum beta-lactamase (ESBL) (a beta-lactam
hydrolase), CTX-M-14, was introduced into a commonly used
laboratory antibiotic-sensitive Escherichia coli strain, DH5. We
subsequently investigated population-based and single-cell-based
performance of the resistant strain under broadly varying antibi-
otic stresses (concentrations). The hydrolase gene appears to be
tightly coupled with growth rate control; antibiotic levels, resis-
tance gene expression, and cell growth form feedback loops exhib-
iting growth plasticity and adaptation to the changing antibiotic
stress.
RESULTS AND DISCUSSION
Host heteroresistance reflects heterogeneous expression of hy-
drolase genes. To see if ESBL genes are related to heteroresistance
and using PAP, we analyzed four ESBL-bearing clinical isolates
from Klebsiella pneumoniae and Escherichia coli, all of which ex-
hibit heteroresistance in the presence of ceftriaxone (Fig. 1a). The
behavior of these strains is in accordance with a previous report
that a blaOXA-58-like gene-encoded hydrolase was demonstrated
to always lead to phenotypic heterogeneous resistance (PHR)
(heteroresistance) to carbapenems in Acinetobacter baumannii
(1).
To carry the investigation further, we first constructed a mo-
lecular model for heteroresistance by introducing a plasmid
(pUA66) carrying an ESBL gene, encoding CTX-M-14, into E. coli
DH5. We also inserted the CTX-M-14 gene promoter upstream
of the green fluorescence protein (GFP) open reading frame
(ORF) (16) (Fig. 1b) so that the fluorescence intensity of GFP
directly reflected the expression of the CTX-M-14 gene. The rea-
son we chose the CTX-M-14 gene for the study is based on its
widely known prevalence (17, 18) and the fact that there is no trans
regulator or cis elements controlling its expression when antibiot-
ics are in action (19). Second, we evaluated heteroresistance and
CTX-M-14 gene expression in the resistant host strain, namely,
E. coli R4. The PAP curve of R4 for ceftriaxone appears similar to
that of the original clinical E. coli isolate from which the CTX-
M-14 gene was cloned, with a slight shift toward the left (Fig. 1a).
FIG 1 A plasmid-bearing ESBL gene leads to heteroresistance. (a) PAPs of four clinical isolates. Four isolates were analyzed, including two E. coli (Eco) strains
(carrying the CTX-M-14 and TEM-10 ESBL genes) and two K. pneumoniae (Kpn) strains (producing CTX-M-65 and SHV-2). Ceftriaxone was the antibiotic
used for all strains. (b) Construction of the plasmid expressing CTX-M-14. (c) Fluorescent image of cells from overnight culture of the resistant strain R4.
Growing cells show significant differences in CTX-M-14-GFP expression. The inset shows a histogram of GFP intensity for the same cell population.
Wang et al.
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The GFP intensity of the R4 overnight culture had a roughly log-
arithmic Gaussian distribution in flow cytometry (FCM), ranging
from 102 to 105 arbitrary units (AU), with a peak at 1,238 AU
(Fig. 1c). Consequently, the CTX-M-14 gene itself was heteroge-
neously expressed and sufficiently led to detectable heteroresis-
tance at the same time.
Hydrolase gene expression in subpopulations correlates pos-
itively with resistance and adaption to variable antibiotic stress.
To further confirm if hydrolase gene expression correlates with
resistance, we flow sorted (fluorescence-activated cell sorting
[FACS]) the top 7% (named the high-intensity group [HIG]) and
the lowest 10% (named the low-intensity group [LIG]) bacterial
populations based on their GFP intensity from an overnight cul-
ture grown in drug-free medium (Fig. 2a). We used Etest to mea-
sure the ceftriaxone MICs of the LIG and HIG, which are 4 g/ml
and 256 g/ml, respectively (Fig. 2b); this result indicates that
higher GFP intensity or more CTX-M-14 hydrolase production
corresponds to stronger resistance. To see if plasmid copy number
variation contributes to the expression of the hydrolase, we quan-
tified copy numbers of both the plasmid and the CTX-M-14 tran-
script in the two GFP intensity groups, using real-time PCR and a
housekeeping gene, gapA, as a reference; the corresponding fold
changes in the copy numbers of the plasmid and the hydrolase
transcript for HIG over LIG are 4.89 and 7.67, respectively
(Fig. 2c). The different fold changes reflect variations in plasmid
copy number and transcription activity between the two sub-
groups.
Further observation uncovered that the hydrolase gene exhib-
ited quantized expression when we cultured the HIG and LIG cells
in antibiotic-free medium immediately after sorting and investi-
gated the dynamic distribution of the expression. The LIG-
associated peak at 732 AU eventually switched to the position of
the antibiotic-free peak at 1,238 AU in ~30 to 60 min. The initial
HIG-associated peak at 23,158 AU faded away in ~4 h and was
replaced by the antibiotic-free peak at 1,238 AU, which emerged at
~60 min (Fig. 2d). In both cases, the peaks did not shift continu-
ously but were replaced by peaks characteristic of the antibiotic-
free condition.
We further examined the antibiotic effect with hydrolase ex-
pression using exponential-phase cells incubated in a series of
double dilutions of ceftriaxone for 3 h. Along with the increased
ceftriaxone dosage, cell proliferation was suppressed (Fig. 3a).
Meanwhile, the average florescence intensities and MIC in Etest
for the entire population shared a common trend, ascending grad-
ually but with a constant shoulder at the dosage interval of 8 to
128 g/ml (Fig. 3b). The result further confirms the correlation
between CTX-M-14 expression and resistance.
The distribution of GFP intensities appeared to be fixed at
several values, which further confirms the discontinuity of CTX-
M-14 hydrolase gene expression. When the antibiotic concentra-
tion varied from 2 to 128g/ml, fluorescence peaked at 4,580 AU.
When the antibiotic concentration reached a higher level,
256g/ml and above, several peaks appeared, with a major one at
13,473 AU (Fig. 3c). This observation suggests the existence of
complex subpopulations, where their CTX-M-14 hydrolase gene
expression is heterogeneous and their proportions adapt to anti-
biotic dosages.
In addition, our microscopic observation confirms that cellu-
lar fluorescence intensity increases with ceftriaxone concentra-
tions and cells grow in a filament-like way in response to higher
concentrations (Fig. 3d). However, flow cytometry can detect only
the total fluorescent intensity of the bacterial particles, which are
often elongated to be severalfold longer than the untreated cells.
Although forward scatter (FSC) reflects particle size in flow cy-
tometry, it is not exactly proportional to particle size, and we
cannot normalize fluorescence to a single cell unit by simply di-
viding by the FSC value.
Increased CTX-M-14 hydrolase expression does not provide
cells with a selective advantage but is associated with a reduced
growth rate. According to the exclusion rule (12), heteroresis-
tance can be a result of heterogeneous expression of antibiotic
hydrolase genes and provides a heterogeneous selective advantage;
when treated with antibiotics, the cells with higher resistance are
selected and form resistant colonies in inhibitory halos. To test
this rule at the single-cell level, we fabricated a PDMS (polydim-
ethylsiloxane) microfluidic device that allows tracing a single bac-
terial cell and recording cellular activity under different antibiotic
stresses. Fluorescence (GFP) intensity can be recorded at each site
of the tiled cells instead of the total value of the entire particle in
flow cytometry. We started the experiment with R4 culture in
exponential phase; 50 randomly selected cells at each ceftriaxone
concentration were monitored for 2 h to observe their colony
formation, GFP intensity, and growth rate.
We found that almost all cells, even dim cells— expressing
CTX-M-14 at a lower level— had excellent viability and displayed
heterogeneity in growth rate and GFP intensity at various antibi-
otic concentrations below 2,048g/ml. We did, however, observe
cell death at an extreme ceftriaxone concentration, 8,196 g/ml,
when some cells died as determined by fluorescence fade-out or
sudden burst after cell wall bulging. Surprisingly, at any antibiotic
concentration, brighter cells (higher GFP/CTX-M-14 expression)
FIG 2 High-intensity group (HIG) and low-intensity group (LIG) cells show
differences in resistance to antibiotics. (a) Sorting gates of HIG and LIG cells.
(b) Etest of LIG (left) and HIG (right) cells. (c) Copy numbers of the plasmid
and CTX-M-14 transcripts in HIG and LIG cells. (d) Dynamic GFP intensity
histograms of HIG and LIG cells after sorting. Cells of both subgroups were
cultured in antibiotic-free medium and sampled for FCM assay every 30 min
for 4 h immediately after sorting. The red dotted line indicates the peak posi-
tion of the whole population under antibiotic-free conditions, and the blue
dotted lines indicate peak positions of the sorted LIG and HIG subpopulations.
Interphenotypic Coordination under Antibiotic Stress
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did not show a significantly higher survival rate than dim ones
(Fig. 4a). Although brighter cells often grow slower, and slow-
growing cells are statistically more resistant to antibiotics
(Fig. 4b), as previously reported (20), we did not observe a direct
relationship between cellular GFP intensity and the survival rate:
even the brightest cells often faded out, a sign of death. We further
constructed a mock plasmid without the CTX-M-14 ORF, but the
GFP ORF remained downstream of the CTX-M-14 gene pro-
moter. Due to the loss of the resistance gene, the sensitive strain
(named S4) could sustain only ceftriaxone concentrations lower
than 128 ng/ml, when cells death became apparent. As expected,
the S4 cell survival rate at a ceftriaxone concentration of 128 ng/ml
showed no relationship with GFP intensity but negatively corre-
lated with the growth rate (Fig. 4c and d).
When cells were treated with a series of ascending ceftriaxone
dosages which the R4 strain can sustain, the mean and variance of
the GFP intensity of the cell population both increased (Fig. 5a),
which is in line with our observations in the flow cytometry ex-
periment. Another major effect of antibiotic treatment was a grad-
ual reduction of the growth rate (Fig. 5a). This observation is in
accordance with the growth curves of the bulk cultures subjected
to the same series of antibiotic treatments. We have now identified
a unique process in R4 when it responds to antibiotic stress. First,
the majority of the cells are fast growing, expressing a low level of
GFP, i.e., a low-expression phenotype. Second, when subjected to
different dosages of ceftriaxone, a subset of cells switch their orig-
inal phenotype to high expression and slow growing, while others
maintain their original low-expression and fast-growth pheno-
type. Third, the percentage of phenotype-switching cells increases
with an elevated antibiotic dosage (Fig. 5b).
We also noticed a phenotype switch happening during the split
of a mother cell into two daughter cells (C1 and C2; Fig. 5e); one
(C1) of the daughter cells retained its original growth rate, with a
relatively slow accumulation of cellular GFP, while C2 acquired
another trend: high expression and slow growth. There seems to
be a control on total activity of cellular growth and hydrolase
expression.
Let us reexamine the concept of heteroresistance, which origi-
nated with colony-based assays (Etest and PAP). In fact, colony
formation is not an indicator of individual living cells inoculated
FIG 3 Effects of antibiotic on the GFP intensity of the R4 strain. (a) Growth curves of the R4 strain cultured in medium containing serially diluted ceftriaxone.
(b) Average fluorescence intensity (left y axis; a.u., arbitrary units) and MIC measured with Etest (right y axis) at the time point of 3 h of ceftriaxone treatment
as shown in panel a. (c) Histograms of GFP intensity after 3 h of ceftriaxone treatment as shown in panel a. The y axis in these histograms indicates the percentage
of the maximum cell count (% Max), and the color lines indicate the ceftriaxone concentrations (g/ml) used. Dotted lines labeled with “L” (low), “M”
(moderate), or “H” (high) indicate the positions of the major peaks, which shift rightward as the ceftriaxone concentration increases. (d) Fluorescence images of
cells after 2 h of ceftriaxone treatment as shown in panel a.
Wang et al.
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on the agar plate, but colony-forming potential depends on dif-
ferences between the growth rate and the death rate in a probabi-
listic manner. According to our results at the single cell level, an-
tibiotic concentrations used in such assays do not select for cells
with “resistant” phenotypes but lead to a general effect of in-
creased CTX-M-14 expression and decreased growth rate through
phenotype switching toward heterogeneity. The gradual reduc-
tion of the growth rate decreases the possibility of colony forma-
tion and leads to a decreased colony count as the antibiotic dosage
increases. Therefore, a clear picture emerges as we take the growth
rate into account. On agar plates with antibiotic, some cells switch
to the high-expression and slow-growing phenotype and hydro-
lyze antibiotic in its surrounding space, creating favorable condi-
tions for their fast-growing progenies (although the progenies
may have the low-expression phonotype) to form colonies. Since
it is not a survival game but a growth game where a clonal popu-
lation is living through antibiotic stress, we hypothesize that a
population-based growth strategy is intrinsic to bacterial species
through phenotype diversification and cooperation among prog-
enies, and thus the subpopulations sacrifice some of their energy
and other resources, such as replication, to CTX-M-14 gene ex-
pression, achieving maximal population survival and propaga-
tion.
Phenotypic heterogeneity of clonal populations has been
found to be a common phenomenon for a long time (21–23).
Heterogeneity is deemed to offer progenies with different selective
advantages in case of unpredictable environmental stresses, such
as the persister phenotype under extreme antibiotic stress (24, 25).
The population has to hedge its bet on different phenotypes and
hope that at least one of the phenotypes may survive when the
others perish. However, in a harsh environment, it may not be
easy for a strain to develop a single phenotype that bears all the
characteristics needed to survive that stress; an effective alterna-
tive strategy is of essence for the population to allocate different
tasks to heterogeneous subpopulations, each with its own capaci-
ty/phenotype based on collaborative strategies and opportunity
gains among the subpopulations. In our study, we identified two
opposite phenotypes, high expression and slow growth being one
and low expression and fast growth the other; neither secured life
independently, but corporately the whole population managed to
obtain its maximal biomass under stresses that are often variable
and certainly unpredictable.
Adaptation to variable antibiotic dosages is achieved by
stringent control of growth-centric feedback loops. Since CTX-
M-14 expressed by the R4 strain is encoded by a well-studied ESBL
gene, whose expression is not antibiotic inducible, one question
remains to be addressed: how cell populations control CTX-M-14
gene expression, adapt to different antibiotic dosages, and thus
display heteroresistance. If there is a regulator controlling hydro-
lase gene expression, it must be a common cellular factor in all
cells, since all hydrolase-possessing clinical isolates we have tested
so far exhibited heteroresistance. Therefore, we ascribe to the
growth rate the role of such a regulator, since it has been recog-
nized as a global negative regulator of gene expression (26). When
a cell dedicates itself to division and growth, generally speaking,
gene expression other than cell reproduction is always repressed.
On the contrary, when a cell stops dividing, transcription and
translation become active and gene products accumulate. Mean-
FIG 4 Survival rates of resistant (R4) and control sensitive (S4) strains at bactericidal ceftriaxone concentrations. (a) Correlation of death rates of R4 cells with
their initial GFP intensities after 2 h of ceftriaxone treatment at the minimal bactericidal concentration (8,192g/ml). Cells were binned according to their initial
GFP intensities. (b) Correlation of death rates of R4 cells with their initial growth rates after the same treatment as for panel a; cells were binned according to their
initial growth rates. (c and d) Graphs corresponding to panels a and b for S4 treated at its minimal bactericidal concentration of ceftriaxone (128 ng/ml). Death
count (black squares) and survival rate (blue squares) were plotted together.
Interphenotypic Coordination under Antibiotic Stress
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FIG 5 Single-cell observation of phenotype transition under antibiotic stress. (a) Box charts showing average GFP intensities and growth rates of the R4 strain
at the end of 2-h treatment in four escalating ceftriaxone concentrations. For each antibiotic dosage, 50 cells were randomly selected and observed. (b) The
distribution of cellular GFP intensity versus the growth rate (frequency in color scale) of R4 cells after the same antibiotic treatment as shown in panel a. (c and
d) Corresponding graphs for the S4 strain. (e) Dynamics of growth rate (GR) and GFP intensity (I) of two daughter cells that have departed from a single mother
cell. The daughter cell C1 shows an exponentially increasing GFP intensity and reduced growth rate, whereas the daughter cell C2 exhibits a relatively lower GFP
intensity but a higher growth rate. (f) Scheme of growth-centric feedback loops that control the expression of hydrolase in a stringent way.
Wang et al.
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while, extensive expression of nonessential genes can also suppress
growth due to an overconsumption of cellular energy and re-
sources. Our results support the idea of cross-inhibition between
growth and CTX-M-14 expression, i.e., all fast-growing cells ex-
press smaller amounts of CTX-M-14 (borne as a nonessential
gene by the cells), whereas all high-expression cells are slow grow-
ing. There is a third subpopulation, where its cells are neither fast
growing nor high expression (Fig. 5b). The reason behind this
remains unclear; one of the possibilities is competitive genes that
are highly expressed in the cells exerting resistance to antibiotic
stress through mechanisms other than CTX-M-14. In addition,
cells in the clonal populations vary their plasmid copy numbers
not only from cell to cell but also from time to time. The growth
rate dependence of expression is particularly pronounced for
genes on a plasmid, which replicates independently of the chro-
mosome and accumulates in high copy number in nondividing
cells, leading to a collective gene dosage effect on expression. In
fact, altering gene dosage is one of the major mechanisms bacteria
used to regulate gene expression (26). This is confirmed by our
results, in which plasmid copy number in the HIG cells is higher
than that in the LIG cells.
We are now able to put together negative feedback connecting
three primary variables: antibiotic concentration, growth rate,
and hydrolase expression (Fig. 5f). The net negative feedback cir-
cuit helps the system to reach a balance; i.e., for each antibiotic
concentration, there should be an adaptive growth rate and level
of hydrolase expression. To test the regulation effect of the feed-
back circuit on hydrolase gene expression and the growth rate, we
compared the behavior of both the resistant (R4) and sensitive
(S4) strains in their endurable ceftriaxone concentration ranges (0
to 64 ng/ml for S4, corresponding to 0 to 2,048g/ml for R4) and
found that S4 cells did not show an obvious gradient in both
growth rate and GFP intensity (Fig. 5c); in other words, cells did
not switch to the high-expression and slow-growing phenotype
(Fig. 5d) without the link of hydrolase expression.
Nested within the three-parameter circuit, growth rate and hy-
drolase expression form double-negative feedback (Fig. 5f). In
systems biology, such double-negative feedback conveys effects
similar to those of positive feedback that augments gene expres-
sion on little stimulation (27). In individual cells, expression of
genes involved in positive feedback is triggered by intrinsic mo-
lecular noise and leads to bi-/multistable expression (28). In our
case, such a circuit may represent a major contributor to the quan-
tized GFP expression observed in flow cytometry. A recent report
demonstrated similar effects of growth-centric positive feedback
that leads to heterogeneity in resistance to other categories of an-
tibiotics and resistance mechanisms (29). Since the growth rate is
a critical parameter sensitive to the intensity of environmental
stresses, growth-centric control of gene expression may be a gen-
eral part of the bacterial response to environmental stresses. Un-
der some conditions, such as in biofilm, cells are found to be
heterogeneous in growth rate, resistance, and extracellular poly-
meric substance secretion (30), where growth control may play
key roles as well in phenotypic heterogeneity and coordination of
population-based strategies for adaptation and survival.
In our study, the growth-centric feedback model provides a
basic explanation for the bacterial population’s response to envi-
ronmental stresses. Through the adaptation circuit, the resistance
gene product (CTX-M-14 in our case) is connected to the strength
of environmental stresses and is accurately controlled without
overconsuming cellular energy and other resources, thus helping
the population as a whole to reach its maximal growth or better
propagation.
Bacterial cellular and population heterogeneity under environ-
mental stresses has been observed and is proposed to be a result of
genetic circuitry (31, 32), expression noise (33, 34), and asymme-
try division (35, 36). Our current view suggests the central role of
growth control, which can be fine-tuned by several cellular mech-
anisms, including rRNA biosynthesis (37), plasmid copy number
control (38), competitiveness in gene expression, and stringent
control of cellular energy. Our study merely provides the simplest
case of heteroresistance, where a single hydrolase gene is the only
resistance mechanism. In the real world, however, clinical isolates
may recruit multiple resistance genes or regulatory elements, such
as those encoding outer membrane proteins or efflux pumps,
which are essential genes of the host cells and are under stringent
regulation as well (39). If a stronger positive feedback loop is pres-
ent, expression of these resistant genes may remain constant un-
der a wider range of antibiotic concentrations, even leading to
on-and-off expression control (40). Thanks to the development of
single-cell technology, such as cell-on-a-chip (23), single-
molecule detection (41), and fluorescence time-lapse microscopy
(42), real-time cell activity can now be traced precisely in both
time and space, helping in deciphering the major controlling fac-
tors of gene expression and growth.
Our results provide a novel insight into mechanisms by which
bacteria adapt to antibiotic stress and a path forward in under-
standing antibiotic resistance assay and treatment. First, cellular
and population heterogeneity of bacterial pathogens may interfere
with clinical assays for drug resistance and provides a compelling
explanation for poor repeatability of MIC or resistance judgment
in some cases. Second, pathogens with weak hydrolase gene ex-
pression may appear to be drug sensitive but exhibit strong resis-
tance after antibiotic treatment that may occur rapidly and even
lead to treatment failure. Application of resistance gene discovery
techniques is of the essence to avoid false-negative results in clin-
ical practice.
Conclusions. In conclusion, our observations at single-cell
resolution provide new insights into bacterial responses to antibi-
otic stress. Bacterial progenies exhibit typical heterogeneity in
both growth rate and stress-related gene expression and deal with
environmental stresses in a collaborative way instead of being se-
lected. Control of the growth rate provides opportunities for the
expression of stress-related genes and is capable of serving as a
critical regulator of these genes. Meanwhile, the growth rate pro-
vides a primary response to environmental stresses and thus
makes gene expression adaptive to stresses through stringent con-
trol of the growth-centric feedback loops. These feedback loops
provide a deeper understanding of how bacteria govern heteroge-
neous phenotypes as an intrinsic strategy to reach maximal pop-
ulation growth under variable environmental stresses. Therefore,
we should always keep in mind that growth-controlled cellular
and population heterogeneity may interfere with identification of
resistant bacterial pathogens and antibiotic treatment in clinical
practice.
MATERIALS AND METHODS
Clinical isolates, Etest, and PAP. All clinical isolates were collected in a
multicenter epidemiological study for bacterial resistance in China from
2006 to 2008. Etests (strips provided by bioMérieux) were used according
Interphenotypic Coordination under Antibiotic Stress
January/February 2014 Volume 5 Issue 1 e00942-13 ® mbio.asm.org 7
 
m
bio.asm
.org
 o
n
 April 3, 2014 - Published by 
m
bio.asm
.org
D
ow
nloaded from
 
to the CLSI (Clinical and Laboratory Standards Institute) protocol and
manufacturer’s instructions with Mueller-Hinton agar plates (BD Difco,
USA). The population analysis profile (PAP) assay was performed as pre-
viously described (43). Briefly, a colony from an overnight plate of each
strain was inoculated and cultured in fresh LB broth for 5 h, and then
101, 102, 104, 105, and 106 dilutions were prepared in saline. An
equal volume (100 l) of each diluted culture was spread onto LB plates
with ceftriaxone or imipenem concentrations of a double-diluted range of
0 to 1,024 g/ml. Colonies were counted after 48 h of culture, and the
log10 CFU/ml value was plotted against the antibiotic concentration.
Ceftriaxone was purchased from Roche (People’s Republic of China).
Plasmid construction. The plasmid pUA66 (kindly provided by Uri
Alon from the Weizmann Institute of Science in Israel) is constructed
based on low-copy-number pSC101 and bears GFP-mut2 with a strong
ribosome binding site as a reporter to measure the rate of transcription
initiation (16). The blaCTX-M-14 genes and upstream sequences in eight
clinical isolates were completely sequenced. They are 100% identical to
that of the CTX-M-14 gene and its upstream sequence (GenBank acces-
sion no. EU418916). The 276-bp upstream sequence of the CTX-M-14
ORF was PCR amplified and inserted into BamHI of pUA66 as the pro-
moter for GFP expression. The sequence of both the promoter and CTX-
M-14 ORF was PCR amplified and inserted into the BglII site. Then, the
plasmid was introduced into DH5 competent cells (Invitrogen, Inc.), a
common host cell for subclones derived from E. coli MG1655, and then
cultured in LB medium.
FCM and cell sorting. All flow cytometry (FCM) experiments were
performed using a Becton-Dickinson FACSCalibur instrument (with ex-
citation and emission light at 488 nm and 525 12.5 nm, respectively, at
a voltage of 650 V for GFP fluorescence). Wild-type DH5 was used as a
GFP-negative control. About 105 to 106 cells (events) within a forward
and side light scatter gate were assayed for the distribution of GFP expres-
sion. FITC gates were used to sort cells with high or low GFP intensity. The
sorted cells were collected in fresh LB medium for further analysis or
culture. Original data were analyzed using the software program Flowjo
(TreeStar, Inc.).
Copy number determination of plasmid and CTX-M-14 transcript.
DNA and RNA of the sorted cells were isolated using a commercial ex-
traction kit (Qiagen bacteria; DNA minikit for DNA isolation and Am-
bion PureLink RNA minikit for RNA isolation). The relative copy number
of the plasmid in each sample was determined by comparing the threshold
cycle (CT) value of the CTX-M-14 gene to that of the chromosomal gene
gapAusing quantitative real-time PCR. All amplifications were performed
on an RT-Cycler amplifier (Capitalbio, China) with SYBR green (SYBR
Premix Ex and TaqTM II; Takara). The relative mRNA of CTX-M-14 was
determined using real-time PCR after being reverse transcribed to cDNA
(PrimeScript RT reagent kit; Takara). Primers were as follows: for CTX-
M-14, F, 5= GGC TCA AAG GCA ATA CGA 3=; R, 5= TTA TCA CCC ACA
GTC CAC GA 3=; for gapA, F, 5= ACT TCG ACA AAT ATG CTG GC 3=; R,
5= CGG GAT GAT GTT CTG GGA A 3=.
Microfluidic chip and time-lapse microscopy. A polydimethylsilox-
ane (PDMS) microfluidic cell-on-a-chip was fabricated with standard soft
lithography, basically according to a previous design (44). Briefly, parallel
thin rectangle culture chambers were used for observation of single-cell
resolution. The chambers inside were supported by a pillar matrix and
kept at a height of 1.5 m to constrain expanding E. coli colonies in
monolayers. A feeding channel with a fast flow of fresh LB exchanged
nutrition and wastes with the culture chambers by diffusion and con-
trolled ceftriaxone concentrations as well. About 107 cells in exponential
phase were resuspended in 50l fresh LB and introduced into the culture
chambers. Images were obtained every 5 min at points of interests by
using a Nikon Ti time-lapse microscopy instrument equipped with a PFS
(perfect focus system) focus-maintaining unit and a charge-coupled-
device (CCD) camera. The temperature of the device is controlled at 37
1°C. We processed time course images using the ImageJ software program
and recorded the fluorescence intensity (AU) and cell length (m). Be-
cause the cells displayed a filamentous shape instead of dividing when
treated with ceftriaxone, the doubling time could not be used to describe
the growth rate in our study. We therefore defined the growth rate for each
time point as dL/(dt · L), which means the elongation rate of each length
unit (where d is differential and L is length of cell).
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